Sionex Continues to Strengthen its Patent Portfolio
Complete the form below to unlock access to ALL audio articles.
Sionex Corporation has announced that the US Patent Office has issued a further seven patents to add to its existing portfolio.
The newly issued US patents;
7,119,328 B2: System for DMS peak resolution.
7,098,449: Spectrometer chip assembly.
7,091,481 B2: Method and apparatus for plasma generation.
7,075,068 B2: Method and apparatus for electrospray augmented high field asymmetric ion mobility spectrometer.
7,045,776 B2: System for collection of data and identification of unknown ion species.
7,030,372: Micromachined field asymmetric ion mobility filter and detection.
7,057,168: Systems for differential mobility analysis.
These newly issued patents add to Sionex’s core IP for the microDMx™ technology and further extend its applicability for a wide range of analysis, monitoring and detection scenarios.
The microDMx technology allows the detection of chemical compounds down to parts per trillion (ppt) levels with a degree of specificity unmatched by any other current technology.
"Sionex is continually strengthening our patent portfolio as a key strategy," said Raanan Miller, Sionex’s founder and chief technology officer.
"Part of that strategy is to foster and develop key relationships and collaborations with world-class research institutes and academia."
"We still have an extremely close relationship with The Charles Stark Draper Laboratory in Cambridge, MA, for developments and improvements to our technology."
